Kiora Pharmaceuticals, Inc. (KPRX)
2.49
-0.02
(-0.80%)
USD |
NASDAQ |
Sep 09, 15:06
Kiora Pharmaceuticals Total Liabilities (Quarterly) : 6.919M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.919M |
| March 31, 2026 | 7.292M |
| December 31, 2025 | 8.127M |
| September 30, 2025 | 7.453M |
| June 30, 2025 | 9.818M |
| March 31, 2025 | 10.32M |
| December 31, 2024 | 10.72M |
| September 30, 2024 | 8.479M |
| June 30, 2024 | 7.713M |
| March 31, 2024 | 7.536M |
| December 31, 2023 | 7.602M |
| September 30, 2023 | 7.792M |
| June 30, 2023 | 6.243M |
| March 31, 2023 | 6.372M |
| December 31, 2022 | 7.271M |
| September 30, 2022 | 7.141M |
| June 30, 2022 | 6.701M |
| March 31, 2022 | 6.378M |
| December 31, 2021 | 5.551M |
| September 30, 2021 | 8.145M |
| June 30, 2021 | 7.646M |
| March 31, 2021 | 7.936M |
| December 31, 2020 | 5.574M |
| September 30, 2020 | 3.284M |
| June 30, 2020 | 3.169M |
| Date | Value |
|---|---|
| March 31, 2020 | 2.870M |
| December 31, 2019 | 3.490M |
| September 30, 2019 | 3.656M |
| June 30, 2019 | 2.424M |
| March 31, 2019 | 2.400M |
| December 31, 2018 | 5.344M |
| September 30, 2018 | 5.552M |
| June 30, 2018 | 5.516M |
| March 31, 2018 | 5.888M |
| December 31, 2017 | 16.23M |
| September 30, 2017 | 15.38M |
| June 30, 2017 | 13.74M |
| March 31, 2017 | 13.15M |
| December 31, 2016 | 10.06M |
| September 30, 2016 | 7.371M |
| June 30, 2016 | 6.315M |
| March 31, 2016 | 5.65M |
| December 31, 2015 | 3.421M |
| September 30, 2015 | 1.409M |
| June 30, 2015 | 0.6426M |
| March 31, 2015 | 0.4127M |
| December 31, 2014 | 5.024M |
| September 30, 2014 | 4.844M |
| June 30, 2014 | 4.845M |
| March 31, 2014 | 3.288M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
| Johnson & Johnson | 116.09B |
| Eli Lilly & Co. | 108.40B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 23.78M |
| Shareholders Equity (Quarterly) | 16.86M |
| Debt to Equity Ratio | 0.0198 |
| Current Ratio | 8.970 |
| Net Debt Paydown Yield | -0.30% |